Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Vor Biopharma Inc shares valued at $6,343,284 were sold by RA CAPITAL MANAGEMENT, L.P. on Oct 29 ’25. At $25.22 per share, RA CAPITAL MANAGEMENT, L.P. sold 251,518 shares. The insider’s holdings dropped to 804,231 shares worth approximately $6.84 million following the completion of this transaction.
Also, RA CAPITAL MANAGEMENT, L.P. sold 124,311 shares, netting a total of over 3,408,230 in proceeds. Following the sale of shares at $27.42 each, the insider now holds 1,055,749 shares.
Before that, RA CAPITAL MANAGEMENT, L.P. had sold 24,579 shares from its account. In a trade valued at $617,424, the Director traded Vor Biopharma Inc shares for $25.12 each. Upon closing the transaction, the insider’s holdings decreased to 24,579 shares, worth approximately $6.63 million.
Analysts at Robert W. Baird upgraded the stock from ‘”a Neutral”‘ to ‘”an Outperform”‘ outlook in a report released in mid October. As of September 24, 2025, Stifel has increased its “Hold” rating to a “Buy” for VOR. Earlier on June 30, 2025, H.C. Wainwright upgraded its rating. Their new recommendation was “a Buy” for VOR stock which previously was a “a Neutral”.
Analyzing VOR Stock Performance
On last trading session, Vor Biopharma Inc [NASDAQ: VOR] rose 13.01% to $8.51. The stock’s lowest price that day was $7.6, but it reached a high of $8.6 in the same session. During the last five days, there has been a surge of approximately 6.91%. Over the course of the year, Vor Biopharma Inc shares have dropped approximately -48.86%. Shares of the company reached a 52-week high of $65.80 on 07/08/25 and a 52-week low of $2.62 on 05/09/25.
Support And Resistance Levels for Vor Biopharma Inc (VOR)
According to the 24-hour chart, there is a support level at 7.87, which, if violated, would cause prices to drop to 7.24. In the upper region, resistance lies at 8.87. The next price resistance is at 9.24. RSI (Relative Strength Index) is 28.43 on the 14-day chart, showing oversold technical sentiment.
Is Vor Biopharma Inc subject to short interest?
Stocks of Vor Biopharma Inc saw a sharp steep in short interest on 2025-11-14 dropping by -0.94 million shares to 0.29 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 1.24 million shares. A decline of -319.85% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.36 of the overall float, the days-to-cover ratio (short ratio) decline to 0.36.
Which companies own the most shares of Vor Biopharma Inc (VOR)?
In terms of Vor Biopharma Inc share price expectations, FactSet research, analysts set an average price target of 55 in the next 12 months, up nearly 630.41% from the previous closing price of $7.53. Analysts anticipate Vor Biopharma Inc stock to reach 64 by 2025, with the lowest price target being 55. In spite of this, 2 analysts ranked Vor Biopharma Inc stock as Buy at the end of 2025. On July 26, 2022, Wedbush assigned a price target of “an Outperform” to the stock and initiated coverage with a $18.
